AGP Picks View all

VivaScore and LivIQ team up on connected diagnostics and care navigation

Aug. 25, 2026
By AI, Created 15:42 UTC, Aug 25, 2026, AGP -

VivaScore and LivIQ have formed a strategic partnership to link AI-powered health intelligence with screening, diagnostics and care pathways for employers, health plans and healthcare organizations. The companies say the collaboration is meant to help identify health risks earlier and move people more quickly from insight to follow-up care.

Why it matters: - The partnership aims to close a common gap in healthcare: turning a health insight into a next step for screening, diagnostics or care. - Employers, health plans and healthcare organizations could use the combined model to spot risks earlier and connect members to services faster. - The companies are targeting preventive care, chronic disease management and population health programs where follow-through is often inconsistent.

What happened: - VivaScore and LivIQ announced a strategic partnership on August 25, 2026, in Delaware. - The collaboration combines VivaScore’s digital health intelligence and engagement platform with LivIQ’s diagnostic screening and care navigation infrastructure. - The companies said the goal is to create a more connected member experience across digital engagement, preventive screening, diagnostics and care pathways.

The details: - VivaScore combines data from contactless health scans, wearables, connected health devices, digital assessments and, when available, clinical and laboratory data. - VivaScore turns that data into an overall score, health and well-being sub-scores, personalized insights and trends. - LivIQ provides diagnostic screening workflows, at-home and onsite testing, laboratory integration, fulfillment, care navigation and population-level reporting. - The companies plan to support use cases including employer and population health programs, cardiometabolic and chronic disease risk identification, cancer prevention and screening pathways, at-home and decentralized diagnostics, connected wearable programs, rural and underserved population health initiatives, longitudinal monitoring and navigation into clinical and preventive services. - The partnership also contemplates embedded deployments through API and SDK integration, letting VivaScore sit inside existing LivIQ or customer experiences. - Those embedded or white-label deployments would be configured for each customer and retain appropriate VivaScore attribution. - VivaScore said it can support customer opportunities through its full digital platform or through embedded, integrated and co-branded deployments. - The companies expect to build customer-specific solutions that combine VivaScore technology with LivIQ’s independently delivered diagnostic, screening, laboratory and care-navigation services. - The partnership framework preserves each company’s technology, intellectual property and clinical responsibilities.

Between the lines: - The deal is less about a single product launch and more about stitching together two parts of the care journey that are often disconnected: digital identification and real-world action. - The embedded-deployment language suggests both companies want to scale through partners without forcing customers to replace existing front ends. - The focus on employer and health-plan settings points to a distribution strategy built around population health programs rather than direct-to-consumer use alone.

What’s next: - The companies said they have already identified multiple opportunities for the platforms to work together. - VivaScore and LivIQ plan to begin putting the partnership into practice. - Future work is expected to include customer-specific deployments and integrated offerings across screening, diagnostics and care navigation.

The bottom line: - VivaScore and LivIQ are trying to make preventive healthcare more actionable by linking health intelligence to diagnostics and follow-up care in one connected workflow. - More information is available in the companies’ announcement and on LivIQ.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

The Delaware Post

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Delaware Post

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.